Bringing Regenerative Therapies to Patients We
Post# of 30028
Posted On: 02/17/2015 9:04:04 AM
Bringing Regenerative Therapies to Patients
We have been developing drug-based therapies to delay/stop the progression of Wolfram Syndrome, and we have made significant progress. In parallel, we need to develop regenerative therapies to treat/replace damaged tissues. We have two pipelines for the regenerative therapies.
1. Stem cell-based therapies.
This requires collaboration with surgeons and bioengineers. We are working on this.
2. Regeneration factor-based therapies.
MANF and its receptors are our targets. We are making progress.
Regenerative Therapy Program should be set up in our hospital to bring these new therapies to our patients.We clearly have to go through regulatory processes. We need infrastructure to bring these therapies to our patients.
Thank you so much for reading my blog. I appreciate your support. I hope you have a wonderful week!
Kindest regards,
Fumi Urano
We have been developing drug-based therapies to delay/stop the progression of Wolfram Syndrome, and we have made significant progress. In parallel, we need to develop regenerative therapies to treat/replace damaged tissues. We have two pipelines for the regenerative therapies.
1. Stem cell-based therapies.
This requires collaboration with surgeons and bioengineers. We are working on this.
2. Regeneration factor-based therapies.
MANF and its receptors are our targets. We are making progress.
Regenerative Therapy Program should be set up in our hospital to bring these new therapies to our patients.We clearly have to go through regulatory processes. We need infrastructure to bring these therapies to our patients.
Thank you so much for reading my blog. I appreciate your support. I hope you have a wonderful week!
Kindest regards,
Fumi Urano
(0)
(0)Amarantus Bioscience Holdings (AMBS) Stock Research Links
Scroll down for more posts ▼